Autoimmunity in the Pathogenesis of Hypertension

Hypertension

Volumn 67, Issue 3, 2016, Pages 477-483

  Rodriguez Iturbe, Bernardo ^a  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

ADAPTIVE IMMUNITY; AUTOIMMUNITY; BLOOD PRESSURE; HUMAN; HYPERTENSION; IMMUNOLOGY;

ADAPTIVE IMMUNITY; AUTOANTIBODIES; AUTOIMMUNITY; BLOOD PRESSURE; HUMANS; HYPERTENSION;

EID: 84958059716     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.115.06418     Document Type: Article

References (79)

1. Dole VP, Dahl LK, Cotzias GC, Eder HA, Krebs ME. Dietary treatment of hypertension; clinical and metabolic studies of patients on the rice-fruit diet. J Clin Invest. 1950; 29: 1189-1206. doi: 10.1172/JCI102357.
2. Dahl LK, Heine M, Tassinari L. Effects of chronia excess salt ingestion. Evidence that genetic factors play an important role in susceptibility to experimental hypertension. J Exp Med. 1962; 115: 1173-1190.
3. Dahl LK, Heine M, Tassinari L. Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion. Nature. 1962; 194: 480-482.
4. Rudemiller NP, Mattson DL. Candidate genes for hypertension: insights from the Dahl S rat [published online ahead of print April 15, 2015]. Am J Physiol Renal Physiol. doi: 10.1152/ajprenal.00092.2015. http: //ajprenal. physiology.org/content/early/2015/04/13/ajprenal.00092.2015.
5. Dahl LK, Heine M, Thompson K. Genetic influence of renal homografts on the blood pressure of rats from different strains. Proc Soc Exp Biol Med. 1972; 140: 852-856.
6. Dahl LK, Heine M, Thompson K. Genetic influence of the kidneys on blood pressure. Evidence from chronic renal homografts in rats with opposite predispositions to hypertension. Circ Res. 1974; 34: 94-101.
7. Jaffé D, Sutherland LE, Barker DM, Dahl LK. Effects of chronic excess salt ingestion. Morphologic findings in kidneys of rats with differing genetic susceptibilities to hypertension. Arch Pathol. 1970; 90: 1-16.
8. Heptinstall RH. Renal biopsies in hypertension. Br Heart J. 1954; 16: 133-141.
9. Gareau RJ, Cartier GE. [Histological study of 55 renal biopsies in hypertensive patients]. Union Med Can. 1955; 84: 1134-1142.
10. Sommers SC, Relman AS, Smithwick RH. Histologic studies of kidney biopsy specimens from patients with hypertension. Am J Pathol. 1958; 34: 685-715.
11. Lombardi D, Gordon KL, Polinsky P, Suga S, Schwartz SM, Johnson RJ. Salt-sensitive hypertension develops after short-term exposure to Angiotensin II. Hypertension. 1999; 33: 1013-1019.
12. Rodríguez-Iturbe B, Pons H, Quiroz Y, Gordon K, Rincón J, Chávez M, Parra G, Herrera-Acosta J, Gómez-Garre D, Largo R, Egido J, Johnson RJ. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int. 2001; 59: 2222-2232. doi: 10.1046/j.1523-1755.2001.00737.x.
13. Quiroz Y, Pons H, Gordon KL, Rincón J, Chávez M, Parra G, Herrera- Acosta J, Gómez-Garre D, Largo R, Egido J, Johnson RJ, Rodríguez- Iturbe B. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition. Am J Physiol Renal Physiol. 2001; 281: F38-F47.
14. Alvarez V, Quiroz Y, Nava M, Pons H, Rodríguez-Iturbe B. Overload proteinuria is followed by salt-sensitive hypertension caused by renal infiltration of immune cells. Am J Physiol Renal Physiol. 2002; 283: F1132-F1141. doi: 10.1152/ajprenal.00199.2002.
15. Vanegas V, Ferrebuz A, Quiroz Y, Rodríguez-Iturbe B. Hypertension in page (cellophane-wrapped) kidney is due to interstitial nephritis. Kidney Int. 2005; 68: 1161-1170. doi: 10.1111/j.1523-1755.2005.00508.x.
16. Rodríguez-Iturbe B, Quiroz Y, Nava M, Bonet L, Chávez M, Herrera- Acosta J, Johnson RJ, Pons HA. Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol Renal Physiol. 2002; 282: F191-F201. doi: 10.1152/ajprenal.0197.2001.
17. Hoch NE, Guzik TJ, Chen W, Deans T, Maalouf SA, Gratze P, Weyand C, Harrison DG. Regulation of T-cell function by endogenously produced angiotensin II. Am J Physiol Regul Integr Comp Physiol. 2009; 296: R208-R216. doi: 10.1152/ajpregu.90521.2008.
18. Franco M, Tapia E, Santamaría J, Zafra I, García-Torres R, Gordon KL, Pons H, Rodríguez-Iturbe B, Johnson RJ, Herrera-Acosta J. Renal cortical vasoconstriction contributes to development of salt-sensitive hypertension after angiotensin II exposure. J Am Soc Nephrol. 2001; 12: 2263-2271.
19. Sánchez-Lozada LG, Tapia E, Johnson RJ, Rodríguez-Iturbe B. Herrera- Acosta J. Glomerular hemodynamic changes associated with arteriolar lesions and tubulointerstitial inflammation. Kidney Int. 2003; 64 (suppl 86): S9-S14.
20. Franco M, Martínez F, Quiroz Y, Galicia O, Bautista R, Johnson RJ, Rodríguez-Iturbe B. Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol. 2007; 293: R251-R256. doi: 10.1152/ajpregu.00645.2006.
21. Johnson RJ, Herrera-Acosta J, Schreiner GF, Rodriguez-Iturbe B. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med. 2002; 346: 913-923. doi: 10.1056/NEJMra011078.
22. Rodríguez-Iturbe B, Pons H, Quiroz Y, Lanaspa MA, Johnson RJ. Autoimmunity in the pathogenesis of hypertension. Nat Rev Nephrol. 2014; 10: 56-62. doi: 10.1038/nrneph.2013.248.
23. Rodríguez-Iturbe B, Pons H, Quiroz Y, Johnson RJ. The immunological basis of hypertension. Am J Hypertens. 2014; 27: 1327-1337. doi: 10.1093/ajh/hpu142.
24. De Miguel C, Das S, Lund H, Mattson DL. T lymphocytes mediate hypertension and kidney damage in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol. 2010; 298: R1136-R1142. doi: 10.1152/ajpregu.00298.2009.
25. De Miguel C, Guo C, Lund H, Feng D, Mattson DL. Infiltrating T lymphocytes in the kidney increase oxidative stress and participate in the development of hypertension and renal disease. Am J Physiol Renal Physiol. 2011; 300: F734-F742. doi: 10.1152/ajprenal.00454.2010.
26. Herrera J, Ferrebuz A, MacGregor EG, Rodriguez-Iturbe B. Mycophenolate mofetil treatment improves hypertension in patients with psoriasis and rheumatoid arthritis. J Am Soc Nephrol. 2006; 17(12 suppl 3): S218-S225. doi: 10.1681/ASN.2006080918.
27. Marvar PJ, Thabet SR, Guzik TJ, Lob HE, McCann LA, Weyand C, Gordon FJ, Harrison DG. Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension. Circ Res. 2010; 107: 263-270. doi: 10.1161/CIRCRESAHA.110.217299.
28. Lob HE, Marvar PJ, Guzik TJ, Sharma S, McCann LA, Weyand C, Gordon FJ, Harrison DG. Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system. Hypertension. 2010; 55: 277-283, 6p following 283. doi: 10.1161/HYPERTENSIONAHA.109.142646.
29. Sriramula S, Cardinale JP, Francis J. Inhibition of TNF in the brain reverses alterations in RAS components and attenuates angiotensin II-induced hypertension. PLoS One. 2013; 8: e63847. doi: 10.1371/journal. pone.0063847.
30. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med. 2007; 204: 2449-2460. doi: 10.1084/jem.20070657.
31. Kasal DA, Barhoumi T, Li MW, Yamamoto N, Zdanovich E, Rehman A, Neves MF, Laurant P, Paradis P, Schiffrin EL. T regulatory lymphocytes prevent aldosterone-induced vascular injury. Hypertension. 2012; 59: 324-330. doi: 10.1161/HYPERTENSIONAHA.111.181123.
32. Viel EC, Lemarié CA, Benkirane K, Paradis P, Schiffrin EL. Immune regulation and vascular inflammation in genetic hypertension. Am J Physiol Heart Circ Physiol. 2010; 298: H938-H944. doi: 10.1152/ajpheart.00707.2009.
33. Franco M, Tapia E, Bautista R, Pacheco U, Santamaria J, Quiroz Y, Johnson RJ, Rodriguez-Iturbe B. Impaired pressure natriuresis resulting in salt-sensitive hypertension is caused by tubulointerstitial immune cell infiltration in the kidney. Am J Physiol Renal Physiol. 2013; 304: F982-F990. doi: 10.1152/ajprenal.00463.2012.
34. Giani JF, Bernstein KE, Janjulia T, Han J, Toblli JE, Shen XZ, Rodriguez-Iturbe B, McDonough AA, Gonzalez-Villalobos RA. Salt sensitivity in response to renal injury requires renal angiotensin-converting enzyme. Hypertension. 2015; 66: 534-542. doi: 10.1161/HYPERTENSIONAHA.115.05320.
35. Ryan MJ. Immune mechanisms in hypertension. In Granger ND, Granger J, eds, Colloquium Series on Integrated System Physiology. San Rafael, CA: Morgan & Claypool Life Sciences; 2013: 33-44.
36. Ryan MJ. An update on immune system activation in the pathogenesis of hypertension. Hypertension. 2013; 62: 226-230. doi: 10.1161/HYPERTENSIONAHA.113.00603.
37. Okuda T, Grollman A. Passive transfer of autoimmune induced hypertension in the rat by lymph node cells. Tex Rep Biol Med. 1967; 25: 257-264.
38. Olsen F. Transfer of arterial hypertension by splenic cells from DOCAsalt hypertensive and renal hypertensive rats to normotensive recipients. Acta Pathol Microbiol Scand C. 1980; 88: 1-5.
39. Svendsen UG. Evidence for an initial, thymus independent and a chronic, thymus dependent phase of DOCA and salt hypertension in mice. Acta Pathol Microbiol Scand A. 1976; 84: 523-528.
40. Svendsen UG. The importance of thymus in the pathogenesis of the chronic phase of hypertension in mice following partial infarction of the kidney. Acta Pathol Microbiol Scand (A). 1977; 85: 539-547.
41. Ba D, Takeichi N, Kodama T, Kobayashi H. Restoration of T cell depression and suppression of blood pressure in spontaneously hypertensive rats (SHR) by thymus grafts or thymus extracts. J Immunol. 1982; 128: 1211-1216.
42. Tuttle RS, Boppana DP. Antihypertensive effect of interleukin-2. Hypertension. 1990; 15: 89-94.
43. Crowley SD, Frey CW, Gould SK, Griffiths R, Ruiz P, Burchette JL, Howell DN, Makhanova N, Yan M, Kim HS, Tharaux PL, Coffman TM. Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension. Am J Physiol Renal Physiol. 2008; 295: F515-F524. doi: 10.1152/ajprenal.00527.2007.
44. Crowley SD, Song YS, Sprung G, Griffiths R, Sparks M, Yan M, Burchette JL, Howell DN, Lin EE, Okeiyi B, Stegbauer J, Yang Y, Tharaux PL, Ruiz P. A role for angiotensin II type 1 receptors on bone marrow-derived cells in the pathogenesis of angiotensin II-dependent hypertension. Hypertension. 2010; 55: 99-108. doi: 10.1161/HYPERTENSIONAHA.109.144964.
45. Mattson DL, Lund H, Guo C, Rudemiller N, Geurts AM, Jacob H. Genetic mutation of recombination activating gene 1 in Dahl salt-sensitive rats attenuates hypertension and renal damage. Am J Physiol Regul Integr Comp Physiol. 2013; 304: R407-R414. doi: 10.1152/ajpregu.00304.2012.
46. Barhoumi T, Kasal DA, Li MW, Shbat L, Laurant P, Neves MF, Paradis P, Schiffrin EL. T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury. Hypertension. 2011; 57: 469-476. doi: 10.1161/HYPERTENSIONAHA.110.162941.
47. Krishnan M, Dowling JK, Ling YH, et al. Inflammasome activity is essential for one kidney/deoxycorticosterone acetate/salt-induced hypertension in mice [published online ahead of print June 23, 2015]. Br J Pharmacol. doi: 10.1111/bph.13230. http: //onlinelibrary.wiley.com/doi/10.1111/bph.13230/abstract; jsessionid=C6A4ADA6CCB44C8515D42F00DCFA79EB.f03t04.
48. Qi J, Zhao XF, Yu XJ, Yi QY, Shi HL, Tan H, Fan XY, Gao HL, Yue LY, Feng ZP, Kang YM. Targeting interleukin-1 beta to suppress sympathoexcitation in hypothalamic paraventricular nucleus in Dahl saltsensitive hypertensive rats [published online ahead of print August 25, 2015]. Cardiovasc Toxicol. doi: 10.1007/s12012-015-9338-7. http: //link. springer.com/article/10.1007%2Fs12012-015-9338-7.
49. Bomfim GF, Echem C, Martins CB, Costa TJ, Sartoretto SM, Dos Santos RA, Oliveira MA, Akamine EH, Fortes ZB, Tostes RC, Webb RC, Carvalho MH. Toll-like receptor 4 inhibition reduces vascular inflammation in spontaneously hypertensive rats. Life Sci. 2015; 122: 1-7. doi: 10.1016/j.lfs.2014.12.001.
50. Rodríguez-Iturbe B, Ferrebuz A, Vanegas V, Quiroz Y, Mezzano S, Vaziri ND. Early and sustained inhibition of nuclear factor-kappaB prevents hypertension in spontaneously hypertensive rats. J Pharmacol Exp Ther. 2005; 315: 51-57. doi: 10.1124/jpet.105.088062.
51. Mathis KW, Broome HJ, Ryan MJ. Autoimmunity: an underlying factor in the pathogenesis of hypertension. Curr Hypertens Rep. 2014; 16: 424. doi: 10.1007/s11906-014-0424-1.
52. Mathis KW, Wallace K, Flynn ER, Maric-Bilkan C, LaMarca B, Ryan MJ. Preventing autoimmunity protects against the development of hypertension and renal injury. Hypertension. 2014; 64: 792-800. doi: 10.1161/HYPERTENSIONAHA.114.04006.
53. Sriramula S, Francis J. Tumor necrosis factor - alpha is essential for angiotensin II-induced ventricular remodeling: role for oxidative stress. PLoS One. 2015; 10.
54. Song XA, Jia LL, Cui W, Zhang M, Chen W, Yuan ZY, Guo J, Li HH, Zhu GQ, Liu H, Kang YM. Inhibition of TNF-α in hypothalamic paraventricular nucleus attenuates hypertension and cardiac hypertrophy by inhibiting neurohormonal excitation in spontaneously hypertensive rats. Toxicol Appl Pharmacol. 2014; 281: 101-108. doi: 10.1016/j.taap.2014.09.004.
55. Gilbert EL, Mathis KW, Ryan MJ. 17β-Estradiol protects against the progression of hypertension during adulthood in a mouse model of systemic lupus erythematosus. Hypertension. 2014; 63: 616-623. doi: 10.1161/HYPERTENSIONAHA.113.02385.
56. Vinh A, Chen W, Blinder Y, Weiss D, Taylor WR, Goronzy JJ, Weyand CM, Harrison DG, Guzik TJ. Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension. Circulation. 2010; 122: 2529-2537. doi: 10.1161/CIRCULATIONAHA.109.930446.
57. Kirabo A, Fontana V, de Faria AP, et al. DC isoketal-modified proteins activate T cells and promote hypertension. J Clin Invest. 2014; 124: 4642-4656. doi: 10.1172/JCI74084.
58. Trott DW, Thabet SR, Kirabo A, Saleh MA, Itani H, Norlander AE, Wu J, Goldstein A, Arendshorst WJ, Madhur MS, Chen W, Li CI, Shyr Y, Harrison DG. Oligoclonal CD8+ T cells play a critical role in the development of hypertension. Hypertension. 2014; 64: 1108-1115. doi: 10.1161/HYPERTENSIONAHA.114.04147.
59. Xiao L, Kirabo A, Wu J, Saleh MA, Zhu L, Wang F, Takahashi T, Loperena R, Foss JD, Mernaugh RL, Chen W, Roberts J II, Osborn JW, Itani HA, Harrison DG. Renal denervation prevents immune cell activation and renal inflammation in angiotensin II-induced hypertension. Circ Res. 2015; 117: 547-557. doi: 10.1161/CIRCRESAHA.115.306010.
60. Rodríguez-Iturbe B, Vaziri ND, Herrera-Acosta J, Johnson RJ. Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. Am J Physiol Renal Physiol. 2004; 286: F606-F616. doi: 10.1152/ajprenal.00269.2003.
61. Parra G, Quiroz Y, Salazar J, Bravo Y, Pons H, Chavez M, Johnson RJ, Rodriguez-Iturbe B. Experimental induction of salt-sensitive hypertension is associated with lymphocyte proliferative response to HSP70. Kidney Int. 2008; 74 (suppl.111): S55-S59.
62. Pons H, Ferrebuz A, Quiroz Y, Romero-Vasquez F, Parra G, Johnson RJ, Rodriguez-Iturbe B. Immune reactivity to heat shock protein 70 expressed in the kidney is cause of salt-sensitive hypertension. Am J Physiol Renal Physiol. 2013; 304: F289-F299. doi: 10.1152/ajprenal.00517.2012.
63. Bauernfeind F, Ablasser A, Bartok E, Kim S, Schmid-Burgk J, Cavlar T, Hornung V. Inflammasomes: current understanding and open questions. Cell Mol Life Sci. 2011; 68: 765-783. doi: 10.1007/s00018-010-0567-4.
64. Land WG. Role of heat shock protein 70 in innate alloimmunity. Front Immunol. 2011; 2: 89. doi: 10.3389/fimmu.2011.00089.
65. Mathur S, Walley KR, Wang Y, Indrambarya T, Boyd JH. Extracellular heat shock protein 70 induces cardiomyocyte inflammation and contractile dysfunction via TLR2. Circ J. 2011; 75: 2445-2452.
66. Kuppner MC, Gastpar R, Gelwer S, Nössner E, Ochmann O, Scharner A, Issels RD. The role of heat shock protein (hsp70) in dendritic cell maturation: hsp70 induces the maturation of immature dendritic cells but reduces DC differentiation from monocyte precursors. Eur J Immunol. 2001; 31: 1602-1609. doi: 10.1002/1521-4141(200105)31: 53.0.CO; 2-W.
67. Bethke K, Staib F, Distler M, Schmitt U, Jonuleit H, Enk AH, Galle PR, Heike M. Different efficiency of heat shock proteins (HSP) to activate human monocytes and dendritic cells: superiority of HSP60. J Immunol. 2002; 169: 6141-6148.
68. Wang Y, Kelly CG, Singh M, McGowan EG, Carrara AS, Bergmeier LA, Lehner T. Stimulation of Th1-polarizing cytokines, C-C chemokines, maturation of dendritic cells, and adjuvant function by the peptide binding fragment of heat shock protein 70 J Immunol. 2002; 169: 2422-2429.
69. Todryk SM, Gough MJ, Pockley AG. Facets of heat shock protein 70 show immunotherapeutic potential. Immunology. 2003; 110: 1-9.
70. Land WG, Memer K. Tissue injury-induced initiation of the adaptive immune response. Transplantation. 2012; 93: e38. doi: 10.1097/TP.0b013e31824e7642.
71. Stocki P, Morris NJ, Preisinger C, Wang XN, Kolch W, Multhoff G, Dickinson AM. Identification of potential HLA class I and class II epitope precursors associated with heat shock protein 70 (HSPA). Cell Stress Chaperones. 2010; 15: 729-741. doi: 10.1007/s12192-010-0184-z.
72. Pockley AG, De Faire U, Kiessling R, Lemne C, Thulin T, Frostegard J. Circulating heat shock protein and heat shock protein antibody levels in established hypertension. J Hypertens. 2002; 20: 1815-1820.
73. Kunes J, Poirier M, Tremblay J, Hamet P. Expression of hsp70 gene in lymphocytes from normotensive and hypertensive humans. Acta Physiol Scand. 1992; 146: 307-311. doi: 10.1111/j.1748-1716.1992.tb09424.x.
74. Li JX, Tang BP, Sun HP, Feng M, Cheng ZH, Niu WQ. Interacting contribution of the five polymorphisms in three genes of Hsp70 family to essential hypertension in Uygur ethnicity. Cell Stress Chaperones. 2009; 14: 355-362. doi: 10.1007/s12192-008-0089-2.
75. Prakken BJ, van der Zee R, Anderton SM, van Kooten PJ, Kuis W, van Eden W. Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis. Proc Natl Acad Sci U S A. 1997; 94: 3284-3289.
76. Prakken BJ, Wendling U, van der Zee R, Rutten VP, Kuis W, van Eden W. Induction of IL-10 and inhibition of experimental arthritis are specific features of microbial heat shock proteins that are absent for other evolutionarily conserved immunodominant proteins. J Immunol. 2001; 167: 4147-4153.
77. Wendling U, Paul L, van der Zee R, Prakken B, Singh M, van Eden W. A conserved mycobacterial heat shock protein (hsp) 70 sequence prevents adjuvant arthritis upon nasal administration and induces IL-10-producing T cells that cross-react with the mammalian self-hsp70 homologue. J Immunol. 2000; 164: 2711-2717.
78. Mattson DL. Infiltrating immune cells in the kidney in salt-sensitive hypertension and renal injury. Am J Physiol Renal Physiol. 2014; 307: F499-F508. doi: 10.1152/ajprenal.00258.2014.
79. Go AS, Mozaffarian D, Roger VL, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation. 2014; 129: e28-e292. doi: 10.1161/01. cir.0000441139.02102.80.